2022.04.08Information Reborna Biosciences, Inc. Named a Finalist in Two Categories for the Informa Pharma Intelligence Awards 2022
2021.10.25News release Notice of Conclusion of Basic Agreement on Business Alliance with Shionogi Pharma Co., Ltd.
2021.04.30News release Reborna Biosciences, Inc. Announces Research Collaboration in Central Nervous System Diseases